三上悠亚久久精品,少妇spa推油被扣高潮,波多野结av衣东京热无码专区,亚洲乱码中文字幕久久孕妇黑人

<source id="04ln3"></source>

<tr id="04ln3"><cite id="04ln3"></cite></tr>

2023-10-17

【Explore the future of the pharmaceutical industry】 Kingfriend will meet you in CPHI Barcelona!

Return

Previous Nothing at all Next Kindos creates the new record for fastest approval by FDA: Dacarbazine for Injection

Relevant recommendations

2024-08-07

NKF's subsidiary Kindos’s self-developed Ropivacaine Hydrochloride Injection gets FDA approval for marketing
2024-06-27

Meitheal Pharmaceuticals Strengthens Biologics Portfolio with an Exclusive Commercial Licensing Agreement for YUSIMRY®, a Biosimilar of Humira®
2024-05-20

Eptifibatide injection approved by USFDA，from Nanjing King-Friend subsidiary
2024-05-14

Enoxaparin Sodium Injection of NKF approved in Egypt
2024-05-14

Kindos’ (subsidiary of NKF) Bortezomib for injection getting approved by NMPA, submitted to NMPA and US FDA

Stock price

13.380

-0.49

?2025 Nanjing King-Friend Biochemical Pharmaceutical Co.Ltd蘇ICP備13012010號

<span id="75nex"></span>